Suppr超能文献

比较 EQ-5D 和 SF-6D 在测量缓解膝关节疼痛的获益时的表现。

Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain.

机构信息

Health Economics Group, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK.

出版信息

Cost Eff Resour Alloc. 2009 Jul 17;7:12. doi: 10.1186/1478-7547-7-12.

Abstract

OBJECTIVE

To assess the practicality, validity and responsiveness of using each of two utility measures (the EQ-5D and SF-6D) to measure the benefits of alleviating knee pain.

METHODS

Participants in a randomised controlled trial, which was designed to compare four different interventions for people with self-reported knee pain, were asked to complete the EQ-5D, SF-6D, and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) at both pre- and post-intervention. For both utility measures, we assessed their practicality (completion rate), construct validity (ability to discriminate between baseline WOMAC severity levels), and responsiveness (ability to discriminate between three groups: those whose total WOMAC score, i) did not improve, ii) improved by <20%, and iii) improved by > or = 20%).

RESULTS

The EQ-5D was completed by 97.7% of the 389 participants, compared to 93.3% for the SF-6D. Both the EQ-5D and SF-6D were able to discriminate between participants with different levels of WOMAC severity (p < 0.001). The mean EQ-5D change was -0.036 for group i), 0.091 for group ii), and 0.127 for group iii), compared to 0.021, 0.023 and 0.053 on the SF-6D. These change scores were significantly different according to the EQ-5D (p < 0.001), but not the SF-6D.

CONCLUSION

The EQ-5D and SF-6D had largely comparable practicality and construct validity. However, in contrast to the EQ-5D, the SF-6D could not discriminate between those who improved post-intervention, and those who did not. This suggests that it is more appropriate to use the EQ-5D in future cost-effectiveness analyses of interventions which are designed to alleviate knee pain.

摘要

目的

评估使用两种效用测量工具(EQ-5D 和 SF-6D)来衡量缓解膝关节疼痛的益处的实用性、有效性和反应性。

方法

在一项旨在比较四种不同干预措施对自报膝关节疼痛患者的随机对照试验中,参与者在干预前后均需完成 EQ-5D、SF-6D 和西部安大略省和麦克马斯特大学骨关节炎指数(WOMAC)。对于两种效用测量工具,我们评估了它们的实用性(完成率)、结构有效性(区分基线 WOMAC 严重程度水平的能力)和反应性(区分三组的能力:那些总 WOMAC 评分,i)没有改善,ii)改善<20%,和 iii)改善>或=20%)。

结果

389 名参与者中,有 97.7%完成了 EQ-5D,而 SF-6D 的完成率为 93.3%。EQ-5D 和 SF-6D 均能区分不同 WOMAC 严重程度的参与者(p<0.001)。组 i)的平均 EQ-5D 变化为-0.036,组 ii)为 0.091,组 iii)为 0.127,而 SF-6D 组分别为 0.021、0.023 和 0.053。这些变化分数在 EQ-5D 上差异显著(p<0.001),但在 SF-6D 上则不然。

结论

EQ-5D 和 SF-6D 的实用性和结构有效性基本相似。然而,与 EQ-5D 不同,SF-6D 无法区分干预后改善和未改善的患者。这表明,在未来旨在缓解膝关节疼痛的干预措施的成本效益分析中,更适合使用 EQ-5D。

相似文献

1
Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain.
Cost Eff Resour Alloc. 2009 Jul 17;7:12. doi: 10.1186/1478-7547-7-12.
5
The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D.
Int J Obes (Lond). 2007 Jan;31(1):189-96. doi: 10.1038/sj.ijo.0803365. Epub 2006 May 9.
6
Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
Spine (Phila Pa 1976). 2019 Jun 1;44(11):E679-E686. doi: 10.1097/BRS.0000000000002939.
10
Comparing cost-utility estimates: does the choice of EQ-5D or SF-6D matter?
Med Care. 2009 Aug;47(8):889-94. doi: 10.1097/MLR.0b013e3181a39428.

引用本文的文献

2
Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis.
Health Qual Life Outcomes. 2019 Apr 17;17(1):68. doi: 10.1186/s12955-019-1129-6.
6
Can Original Knee Society Scores Be Used to Estimate New 2011 Knee Society Scores?
Clin Orthop Relat Res. 2017 Jan;475(1):160-167. doi: 10.1007/s11999-016-4886-0.
8
Can The EQ-5D Detect Meaningful Change? A Systematic Review.
Pharmacoeconomics. 2015 Nov;33(11):1137-54. doi: 10.1007/s40273-015-0295-6.

本文引用的文献

1
Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D.
Br J Psychiatry. 2009 Aug;195(2):170-7. doi: 10.1192/bjp.bp.108.057380.
2
Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
J Rheumatol. 2009 Jun;36(6):1209-16. doi: 10.3899/jrheum.081022. Epub 2009 Apr 15.
7
Economic evaluation and decision making in the UK.
Pharmacoeconomics. 2006;24(11):1133-42. doi: 10.2165/00019053-200624110-00009.
8
The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D.
Int J Obes (Lond). 2007 Jan;31(1):189-96. doi: 10.1038/sj.ijo.0803365. Epub 2006 May 9.
10
Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets.
J Health Econ. 2006 Mar;25(2):334-46. doi: 10.1016/j.jhealeco.2005.09.003. Epub 2005 Nov 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验